WILCO startup cluster December 5, 2018 tokyonne News HEPHAISTOS-Pharma was selected by WILCO startup cluster to obtain capital loans and increase our own funds. Share ThisTweetShareShareEmail Related Posts “Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket… HEPHAISTOS secures €10.3 M to reach the clinical stage HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from… EIC accelerator Grant Competition Winner 🏆 We are very proud to announce that we are winners of the #EIC_Accelerator grant…
“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket…
HEPHAISTOS secures €10.3 M to reach the clinical stage HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a total of €10.3 million from…
EIC accelerator Grant Competition Winner 🏆 We are very proud to announce that we are winners of the #EIC_Accelerator grant…